Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
astrazeneca
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
4
×
pfizer
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
4
×
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
clinical trials
fda
microbiome
startups
alzheimer's disease
amgen
avexis
What
bio
roundup
drug
biotech
fda
news
week
acquisitions
alzheimer’s
annual
approved
assessed
attention
august
biggest
build
busy
buy
ceo
communities
companies
company’s
conference
daniel
days
debut
decisions
devices
digital
disease
drugs
dyne’s
epidemic
esmo
europe
fatty
frenzied
germany
gilead
growing
Language
unset
Current search:
astrazeneca
×
pfizer
×
" new york top stories "
×
" eli lilly "
×
" texas blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More